Translational imaging endpoints to predict treatment response to novel targeted anticancer agents.
about
MRI reveals the in vivo cellular and vascular response to BEZ235 in ovarian cancer xenografts with different PI3-kinase pathway activity.Multi-modality imaging to assess metabolic response to dichloroacetate treatment in tumor models.The Importance of Biopsy in the Era of Molecular Medicine.Drugs for solid cancer: the productivity crisis prompts a rethink.Developing an objective marker to optimize patient selection and predict survival benefit in early-phase cancer trials.Translation in solid cancer: are size-based response criteria an anachronism?
P2860
Translational imaging endpoints to predict treatment response to novel targeted anticancer agents.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Translational imaging endpoint ...... el targeted anticancer agents.
@ast
Translational imaging endpoint ...... el targeted anticancer agents.
@en
type
label
Translational imaging endpoint ...... el targeted anticancer agents.
@ast
Translational imaging endpoint ...... el targeted anticancer agents.
@en
prefLabel
Translational imaging endpoint ...... el targeted anticancer agents.
@ast
Translational imaging endpoint ...... el targeted anticancer agents.
@en
P2860
P1476
Translational imaging endpoint ...... el targeted anticancer agents.
@en
P2093
Natalie J Serkova
P2860
P304
P356
10.1016/J.DRUP.2011.04.004
P577
2011-06-02T00:00:00Z